Symbiotec Pharmalab is launching its IPO on August 24, aiming to raise ₹1,757 crore at a price band of ₹938– ₹988 per share. The offering will be open until August 27, with a minimum investment of ₹14,820 for retail investors.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.